News Release

02/28/2013

Release

Patent established additional usage in Japan of F647 and F351 to cover application for Preventing Radiation-Caused Lung Injury in Japan, also in the U.S. obtained patent for pharmaceutical composition of F200

02/14/2013

Release

Announcement of the 12th Annual General Shareholder Meeting

02/04/2013

Release

Submission of Manufacturing and Distribution Permission Application regarding IPF treatment drug, F647

01/23/2013

Release

GNI Seeks New Indication for F647 (Pirfenidone)

01/16/2013

Release

Notice of Increasing the Capital of Shanghai Genomics

11/29/2012

Information

The Beijing Evening News channel visited Beijing Continent Pharmaceuticals for its pirfenidone product development program and interviewed Dr. Ying Luo.

10/30/2012

Event Calendar

G20 Innovation Award

10/17/2012

Information

F351 clinical trial for liver fibrosis

06/18/2012

Event Calendar

BIO2012

06/12/2012

Release

Patent Allowance for Pirfenidone／F647 and its Derivative’s Use in Radiation-Caused Lung Injury

06/04/2012

Release

Notice of Subsidiary Company Establishment of Shanghai Genomics Inc.

04/30/2012

Information

The China Pharmaceutical & Biotechnology Review, a monthly publication covering all aspects of the industry (2012 volume 58), published a panel discussion with Dr. Ying Luo and other Experts from biotechs and research institutes in China.

03/16/2012

Information

Research Findings of F573 Published

03/11/2012

Event Calendar

Drug Discovery World Asia 2012

02/29/2012

Release

Notice for Manufacturing and Distribution Permission regarding IPF treatment drug, F647